UNSPSC 51373453: Codeine/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373453 Codeine/phenylephrine/pyrilamine is a Commodity code that encompasses pharmaceuticals and over-the-counter products state and local governments procure through wholesalers and direct purchase agreements. Recent solicitations under this code show state and local buyers acquiring naloxone and drug deactivation systems for community health initiatives, as well as generic multi-source pharmaceuticals and OTC products through cooperative purchasing arrangements. The mix of issuing bodies includes county health departments and multi-state cooperative purchasing alliances administering on behalf of state and local government facilities, school districts, and other public entities. Work scoped under the code ranges from one-time or recurring purchases of specific pharmaceutical products to comprehensive generic drug supply agreements with pricing flexibility through flat-fee, net-price, or WAC-minus structures.

Geographic activity spans Florida, Minnesota, and Oregon based on recent solicitations. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, with vendors required to include shipping and delivery costs in their bids and maintain workers' compensation, commercial general liability, and professional liability coverage. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in multiple states including Oregon; vendors must certify cGMP and DSCSA compliance, maintain relationships with at least two of three authorized wholesalers, and expect to pay a 3 percent administrative fee on all contract purchases with performance penalties for violations ranging from $200 to $1,500.